These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29228216)

  • 1. Recurrence following curative intended surgery for an adenocarcinoma in the gastroesophageal junction: a retrospective study.
    Belmouhand M; Svendsen LB; Kofoed SC; Normann G; Baeksgaard L; Achiam MP
    Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29228216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathoracic anastomotic leakage after gastroesophageal cancer resection is associated with increased risk of recurrence.
    Kofoed SC; Calatayud D; Jensen LS; Helgstrand F; Achiam MP; De Heer P; Svendsen LB;
    J Thorac Cardiovasc Surg; 2015 Jul; 150(1):42-8. PubMed ID: 25986493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma.
    Jiang DM; Suzuki C; Espin-Garcia O; Lim CH; Ma LX; Sun P; Sim HW; Natori A; Chan BA; Moignard S; Chen EX; Liu G; Swallow CJ; Darling GE; Wong R; Jang RW; Elimova E
    Cancer Med; 2020 May; 9(9):3023-3032. PubMed ID: 32130793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting recurrence in patients with Siewert type II carcinoma treated with curative resection.
    Fukuchi M; Mochiki E; Suzuki O; Ishiguro T; Sobajima J; Onozawa H; Imaizumi H; Shibata K; Saito K; Naitoh H; Kumagai Y; Ishibashi K; Ishida H
    Anticancer Res; 2015 Jan; 35(1):505-9. PubMed ID: 25550595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and recurrence patterns after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophagogastric adenocarcinoma.
    Sudarshan M; Alcindor T; Ades S; Aloraini A; van Huyse M; Asselah J; David M; Frechette D; Brisson S; Thirlwell M; Ferri L
    Ann Surg Oncol; 2015 Jan; 22(1):324-30. PubMed ID: 25023544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes of Endoscopic Submucosal Dissection for Adenocarcinoma of the Esophagogastric Junction.
    Gong EJ; Kim do H; So H; Ahn JY; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Kim JH
    Dig Dis Sci; 2016 Sep; 61(9):2666-73. PubMed ID: 27112341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lauren Histologic Type Is the Most Important Factor Associated With Pattern of Recurrence Following Resection of Gastric Adenocarcinoma.
    Lee JH; Chang KK; Yoon C; Tang LH; Strong VE; Yoon SS
    Ann Surg; 2018 Jan; 267(1):105-113. PubMed ID: 27759618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk factors of early recurrence and prognosis for patients with adenocarcinoma of gastroesophageal junction after curative resection].
    Tang P; Zhang HD; Yu ZT
    Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(45):3594-7. PubMed ID: 24534309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What to do after R1-resection of adenocarcinomas of the esophagogastric junction?
    Gertler R; Richter J; Stecher L; Nitsche U; Feith M
    J Surg Oncol; 2016 Sep; 114(4):428-33. PubMed ID: 27333949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence Following Anastomotic Leakage After Surgery for Carcinoma of the Distal Esophagus and Gastroesophageal Junction: A Systematic Review.
    Aurello P; Berardi G; Moschetta G; Cinquepalmi M; Antolino L; Nigri G; D'Angelo F; Valabrega S; Ramacciato G
    Anticancer Res; 2019 Apr; 39(4):1651-1660. PubMed ID: 30952703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study.
    Xu H; Zhang L; Miao J; Liu S; Liu H; Jia T; Zhang Q
    World J Surg Oncol; 2020 Jun; 18(1):144. PubMed ID: 32593312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction.
    Yoshinaga S; Gotoda T; Kusano C; Oda I; Nakamura K; Takayanagi R
    Gastrointest Endosc; 2008 Feb; 67(2):202-9. PubMed ID: 18226681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
    Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
    Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence.
    Lagarde SM; de Boer JD; ten Kate FJ; Busch OR; Obertop H; van Lanschot JJ
    Ann Surg; 2008 Jan; 247(1):71-6. PubMed ID: 18156925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
    Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
    Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer.
    Climent M; Hidalgo N; Vidal Ó; Puig S; Iglesias M; Cuatrecasas M; Ramón JM; García-Albéniz X; Grande L; Pera M
    Eur J Surg Oncol; 2016 Jan; 42(1):132-9. PubMed ID: 26385054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction.
    Mine S; Sano T; Hiki N; Yamada K; Kosuga T; Nunobe S; Yamaguchi T
    Br J Surg; 2013 Jul; 100(8):1050-4. PubMed ID: 23754647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
    Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
    Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical approach and results of surgery in adenocarcinoma of the gastro-oesophageal junction.
    Ti TK
    Singapore Med J; 2000 Jan; 41(1):14-8. PubMed ID: 10783674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.